Portola Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
CTLTCatalent, Inc. 0.41%81.122.1%$224.89m
SAVACassava Sciences, Inc. 12.36%10.910.0%$191.37m
JAZZJazz Pharmaceuticals Plc -0.33%137.602.4%$166.77m
HZNPHorizon Therapeutics Plc 2.66%77.335.8%$164.09m
MRNSMarinus Pharmaceuticals, Inc. 4.34%11.167.8%$125.41m
CORTCorcept Therapeutics, Inc. 1.94%17.105.5%$120.42m
VRXValeant Pharmaceuticals International, Inc. -0.99%15.0714.1%$88.67m
BHCBausch Health Cos., Inc. -0.97%15.070.0%$60.92m
MYOKMyoKardia, Inc. 0.49%130.651.8%$58.30m
AMRNAmarin Corp. Plc 1.37%3.691.5%$55.76m
ARGXargenx SE 1.23%246.070.0%$55.73m
SAGESAGE Therapeutics, Inc. 0.85%59.408.6%$46.16m
GWPHGW Pharmaceuticals Plc 0.05%98.556.2%$40.35m
AXSMAxsome Therapeutics, Inc. 1.54%77.101.9%$39.40m
PRGOPerrigo Co. Plc -0.60%44.726.8%$35.67m

Company Profile

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.